Trial Profile
Phase I trial of ITV-1, a peptide vaccine for HIV-AIDS, in volunteers in Bulgaria
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2013
Price :
$35
*
At a glance
- Drugs ITV 1 (Primary)
- Indications Acquired immunodeficiency syndrome; HIV infections
- Focus Adverse reactions
- Sponsors Immunotech Laboratories
- 15 Feb 2013 New trial record
- 13 Feb 2013 Results have been highly successful in Bulgaria, according to an Immunotech Laboratories media release.